THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics Inc. (NasdaqCM:RPRX) today announced that it believes that it has regained compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market.
THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics Inc. (NasdaqCM:RPRX) today announced that it believes that it has regained compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market.
